Medtronic has secured an FDA green light for a new type of implantable cardioverter-defibrillator that the medtech giant describes as the first of its kind. Unlike other ICDs that are wired into ...
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
EV-ICD defibrillation lead placed outside of heart and veins, preserving vasculature DUBLIN, Feb. 17, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT) has received CE (Conformité Européenne) Mark for the ...
Medtronic has received U.S. regulatory approval to sell a new implantable defibrillator that can be placed outside of the heart and veins to treat SCA — sudden cardiac arrest — an electrical problem ...
New System Builds On Sprint Quattro® Lead, Adding to the Company’s Portfolio of Innovative Technologies Proven to Treat Heart Rhythm Disorders MINNEAPOLIS – Medtronic, Inc. today announced the U.S.
Please provide your email address to receive an email when new articles are posted on . Medtronic recalled ICDs and CRT-Ds with a glassed feedthrough made after Oct. 13, 2017 due to risk for low- or ...
The Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD) by Medtronic aims to assess the recurrence of unstable ventricular tachycardia (VT) in patients who ...
2020 DEC 01 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily-- Fresh data on Life Science Research are presented in a new report. According to news originating from ...
Evera MRI ICD System Approved for Use During Full Body MRI Scans for Patients at Risk of Sudden Cardiac Arrest DUBLIN - Sept. 14, 2015 - Medtronic plc today announced that it has received the first ...
Medtronic MDT recently declared the findings of its investigational Extravascular Implantable Cardioverter–Defibrillator (EV ICD) Study. These were presented as late-breaking science at Heart Rhythm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback